Results 21 to 30 of about 600,294 (239)

The benefits of in silico modeling to identify possible small-molecule drugs and their off-target interactions [PDF]

open access: yes, 2018
Accepted for publication in a future issue of Future Medicinal Chemistry.The research into the use of small molecules as drugs continues to be a key driver in the development of molecular databases, computer-aided drug design software and collaborative ...
Blomberg N   +6 more
core   +2 more sources

BiComp-DTA: Drug-target binding affinity prediction through complementary biological-related and compression-based featurization approach.

open access: yesPLoS Computational Biology, 2023
Drug-target binding affinity prediction plays a key role in the early stage of drug discovery. Numerous experimental and data-driven approaches have been developed for predicting drug-target binding affinity.
Mahmood Kalemati   +2 more
doaj   +1 more source

Evolutionary conservation of influenza A PB2 sequences reveals potential target sites for small molecule inhibitors. [PDF]

open access: yes, 2017
The influenza A basic polymerase protein 2 (PB2) functions as part of a heterotrimer to replicate the viral RNA genome. To investigate novel PB2 antiviral target sites, this work identified evolutionary conserved regions across the PB2 protein sequence ...
Kukol, A.   +3 more
core   +3 more sources

Quantitative prediction model for affinity of drug–target interactions based on molecular vibrations and overall system of ligand-receptor

open access: yesBMC Bioinformatics, 2021
Background The study of drug–target interactions (DTIs) affinity plays an important role in safety assessment and pharmacology. Currently, quantitative structure–activity relationship (QSAR) and molecular docking (MD) are most common methods in research ...
Xian-rui Wang   +4 more
doaj   +1 more source

DeepMHADTA: Prediction of Drug-Target Binding Affinity Using Multi-Head Self-Attention and Convolutional Neural Network

open access: yesCurrent Issues in Molecular Biology, 2022
Drug-target interactions provide insight into the drug-side effects and drug repositioning. However, wet-lab biochemical experiments are time-consuming and labor-intensive, and are insufficient to meet the pressing demand for drug research and ...
Lei Deng   +4 more
doaj   +1 more source

Target identification of small molecules: an overview of the current applications in drug discovery

open access: yesBMC Biotechnology, 2023
Target identification is an essential part of the drug discovery and development process, and its efficacy plays a crucial role in the success of any given therapy.
Yasser Tabana   +4 more
doaj   +1 more source

Predicting kinase inhibitor resistance: Physics-based and data-driven approaches. [PDF]

open access: yes, 2019
Resistance to small molecule drugs often emerges in cancer cells, viruses, and bacteria as a result of the evolutionary pressure exerted by the therapy.
Aldeghi, M., de Groot, B., Gapsys, V.
core   +1 more source

Binding mode analyses of NAP derivatives as mu opioid receptor selective ligands through docking studies and molecular dynamics simulation [PDF]

open access: yes, 2017
Mu opioid receptor selective antagonists are highly desirable because of their utility as pharmacological probes for receptor characterization and functional studies.
Wang, Huiqun   +2 more
core   +2 more sources

Prediction of drug–target binding affinity using similarity-based convolutional neural network

open access: yesScientific Reports, 2021
Identifying novel drug–target interactions (DTIs) plays an important role in drug discovery. Most of the computational methods developed for predicting DTIs use binary classification, whose goal is to determine whether or not a drug–target (DT) pair ...
Jooyong Shim   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy